Evidence map›Paper›PMID 25125896›Full record

ArticleUrology annals2014

Primary Diffuse large B-Cell lymphoma of testis: A single centre experience and review of literature.

Kadabur Nagendrapp Lokesh, Vishwanath Sathyanarayanan, C Lakshmaiah Kuntegowdanahalli, T M Suresh, Lokanatha Dasappa, Govinda Babu K Kanakasetty

Open access · goldAbstract read
In one paragraph

Article in Urology annals, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Utility of FDG PET/CT in the Management of Primary Testicular Lymphoma.Molecular imaging and radionuclide therapy · 2018
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kadabur Nagendrapp LokeshDepartment of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
Vishwanath SathyanarayananDepartment of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
C Lakshmaiah KuntegowdanahalliDepartment of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
T M SureshDepartment of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
Lokanatha DasappaDepartment of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
Govinda Babu K KanakasettyDepartment of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
Kidwai Memorial Institute of Oncology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary testicular lymphoma constitutes 1-2% of Non-Hodgkin's lymphomas affecting elderly men >60 years of age. Most often it is a Diffuse large B cell lymphoma (DLBCL) and treatment involves multimodality approach involving surgery, chemotherapy and radiotherapy. Outcome remains poor in spite of aggressive therapy. MATERIALS AND

methodsWe retrospectively reviewed 286 registered cases of DLBCL (aged >14 years) from 2007 to 2011 and found nine primary testicular involvement patients. These cases were analyzed for baseline clinical features, investigations, staging, treatment and outcome.

resultsMedian age was 58 (46-76) years. All patients presented with testicular swelling, two had the presence of B symptoms, and three with abdominal lymphadenopathy. Six had stage IE disease and three patients had stage IIE. All patients underwent orchiectomy. Eight patients received combination chemotherapy and six completed three or more cycles. Four achieved complete response, among these three relapsed after 32, 42, 70 months and one was lost to follow up. Two had a progressive disease, among these one died of disease and one alive with disease. Complete follow up was available from five patients and median survival was 36 months (11-78 months).

conclusionPrimary testicular DLBCL is uncommon, needs multimodality treatment and central nervous system prophylaxis to improve the survival. The outcome needs to be further investigated using biological approaches (Rituximab based) and/or more aggressive management.

Indexed as

Diffuse large B cell lymphomaNon-Hodgkin's lymphomatestis

Identifiers

PMID25125896
PMCPMC4127860
OpenAlexW1965982055

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.